+44 1463 214783

Clinical Practice

CCE is approved across all of Europe, Japan, Canada, and other countries as a viable procedure for colorectal cancer screening. However, to bring it into clinical practice and make it part of the toolbox a medical professional can tap into to make the best possible diagnosis, this additional study will be conducted. The overall study comprises the trial with 250 patients as described above as well as multiple other ones that look at over 3,000 patients in a normal HD-CCE delivery, i.e. without that additional colonoscopy.